Log in to save to my catalogue

Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer’s...

Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer’s...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5f3b317f18a94dfbb108df54eea815d3

Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer’s disease

About this item

Full title

Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer’s disease

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2020-09, Vol.11 (1), p.1-11, Article 4790

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Preventing aggregation of amyloid beta (Aβ) peptides is a promising strategy for the treatment of Alzheimer’s disease (AD), and gold nanoparticles have previously been explored as a potential anti-Aβ therapeutics. Here we design and prepare 3.3 nm L- and D-glutathione stabilized gold nanoparticles (denoted as L3.3 and D3.3, respectively). Both chir...

Alternative Titles

Full title

Chiral gold nanoparticles enantioselectively rescue memory deficits in a mouse model of Alzheimer’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5f3b317f18a94dfbb108df54eea815d3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5f3b317f18a94dfbb108df54eea815d3

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-020-18525-2

How to access this item